2005 Annual Meeting | Stroke Therapy

Date Thursday 04/14/05

Time 07:00 PM - 09:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Therapy Program

Director(s) Pierre Fayad, MD, FAHA, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should become familiar with the latest information and breakthroughs on the acute and intensive care treatment of acute ischemic and hemorrhagic stroke; the surgical and interventional therapies for the treatment and prevention of hemorrhagic stroke; and the medical, surgical, and interventional therapies for ischemic stroke prevention.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
07:00 PM - 07:30 PM		Acute and Intensive Care Treatment of Acute and Hemorrhagic Stroke Stephan A. Mayer, MD
07:00 PM - 09:00 PM		Refreshments
07:30 PM - 07:40 PM		Questions and Answers
07:40 PM - 08:10 PM		Surgical and Interventional Therapies for the Treatment and Prevention of Hemorrhagic Stroke Issam Awad, MD
08:10 PM - 08:20 PM		Questions and Answers
08:20 PM - 08:50 PM		Medical, Surgical, and Interventional Therapies for the Prevention of Ischemic Stroke Pierre Fayad, MD, FAHA, FAAN
08:50 PM - 09:00 PM		Questions and Answers

Faculty Disclosures
Pierre Fayad, MD, FAHA, FAAN	Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Stephan A. Mayer, MD	Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Braincool. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MaxQ AI. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Mayer has received stock or an ownership interest from Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Issam Awad, MD	No disclosure on file